dihydroergotamine has been researched along with Bipolar Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, M; Guidet, B; Janneau-Magrino, L; Legendre, N; Pateron, D; Yordanov, Y | 1 |
| Guilhaume, B; Lesgourgues, B; Luton, JP; Neveux, E; Picard, J | 1 |
2 other study(ies) available for dihydroergotamine and Bipolar Disorder
| Article | Year |
|---|---|
Human immunodeficiency virus post-exposure prophylaxis: primum non nocere.
Topics: Adult; Antiviral Agents; Bipolar Disorder; Cytochrome P-450 CYP3A Inhibitors; Dihydroergotamine; Drug Synergism; Drug Therapy, Combination; Ergotism; Female; HIV Infections; Humans; Hypotension, Orthostatic; Lamivudine; Lopinavir; Post-Exposure Prophylaxis; Ritonavir; Vasoconstrictor Agents; Zidovudine | 2015 |
[Acute ergotism caused by the interaction of erythromycin propionate and dihydroergotamine].
Topics: Acute Disease; Bipolar Disorder; Dihydroergotamine; Drug Synergism; Ergotism; Erythromycin; Humans; Male; Middle Aged | 1981 |